Nanomedicine in Drug Delivery
262,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
131 °P sammeln
  • Gebundenes Buch

Recent breakthroughs in nanomedicine are now making it possible to deliver drugs and therapeutic proteins to local areas of disease or tumors to maximize clinical benefit while limiting unwanted side effects. This book gives an overview of aspects of nanomedicine to help readers design and develop novel drug delivery systems and devices that build on nanoscale technologies. Contributors explore the use of nanoparticles in inhalation aerosols, nanodermatology, wound healing, bioimaging, anticancer drug delivery, ocular drug delivery, and more. They also discuss nanotoxicity and safety studies.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Recent breakthroughs in nanomedicine are now making it possible to deliver drugs and therapeutic proteins to local areas of disease or tumors to maximize clinical benefit while limiting unwanted side effects. This book gives an overview of aspects of nanomedicine to help readers design and develop novel drug delivery systems and devices that build on nanoscale technologies. Contributors explore the use of nanoparticles in inhalation aerosols, nanodermatology, wound healing, bioimaging, anticancer drug delivery, ocular drug delivery, and more. They also discuss nanotoxicity and safety studies.
Autorenporträt
Arun Kumar, Ph.D., is an assistant professor in the Department of Medical Laboratory Science and the Department of Biomedical Engineering at the University of Delaware. Dr. Kumar has filled in more than 26 patents on his research related to biosensors and nanotechnology. He has presented his work at more than 60 international conferences worldwide, published more than 35 peer-reviewed research articles and two book chapters, and is an editorial board member of Sensors and Transducers Journal. Heidi M. Mansour, Ph.D., RPh, is an assistant professor of pharmaceutics and drug delivery at the University of Kentucky College of Pharmacy, a faculty associate at the University of Kentucky Center of Membrane Sciences, and a graduate faculty member at the University of North Carolina-Chapel Hill. She serves on the editorial advisory boards of eight journals in drug delivery and nanomedicine, is a member of the NIH U.S. Pediatric Formulations Initiative New Drug Delivery Systems Aerosols Working Group, and is a delegate to the U.S. Pharmacopeia (USP). Dr. Mansour has published more than 40 peer-reviewed scientific publications, five book chapters, and more than 80 abstracts. Adam Friedman, MD, FAAD, is an assistant professor of dermatology and physiology/biophysics and serves as director of the Dermatologic Research at the Unified Division of Dermatology of Albert Einstein College of Medicine. Dr. Friedman investigates novel nanotechnologies that allow for controlled and sustained delivery of a wide spectrum of physiologically and medicinally relevant molecules. He holds several patents and has published more than 80 papers/chapters on his research as well as on a variety of clinical areas in dermatology. Dr. Friedman recently published the first textbook on nanotechnology and dermatology and serves as vice president of the Nanodermatology Society. Eric Blough, Ph.D., is an associate professor and director of pharmacology and toxicology at the School of Pharmacy at Marshall University. In addition to his academic duties he is also the director for the Center for Diagnostic Nanosystems. A prolific researcher and publisher, Dr. Blough and his colleagues have received over $11 million in research awards since 1998 and published more than 150 scientific manuscripts, technical reports, and abstracts-all while maintaining a strong focus on student development and mentoring in his teaching.